Hong Kong Electronic Equipment and Components Stock News

Sisram Medical (SEHK:1696) has released its FY 2025 first half results, reporting revenue of US$165.5 million and basic EPS of US$0.0137, setting the stage against a backdrop of trailing twelve month revenue of US$365.3 million and EPS of US$0.0406. The company has seen revenue move from US$168.7 million and EPS of US$0.0234 in the first half of 2024 to US$180.4 million and EPS of US$0.0303 in the second half of 2024, giving you a clear view of how the latest numbers sit within its recent...

SEM Holdings (SEHK:9929) has laid out a mixed set of FY 2025 numbers, with first half revenue of HK$21.5 million and basic EPS of HK$0.00011, while the trailing twelve months to the second half of FY 2025 show revenue of HK$66.3 million and a loss per share of HK$0.0094. Over recent reporting periods, the company has seen revenue shift from HK$50.9 million in the first half of FY 2024 to HK$40.8 million in the second half of FY 2024 and then to HK$21.5 million in the first half of FY 2025...

WH Group (SEHK:288) has set out its FY 2025 scorecard with second half revenue of about US$14.6b and basic EPS of US$0.0607, while trailing twelve month revenue sits at roughly US$28.0b with EPS of US$0.1221. Over recent periods the company has seen revenue move from about US$13.6b in 2H 2024 to US$13.4b in 1H 2025 and then to US$14.6b in 2H 2025, with basic EPS shifting from US$0.0645 in 2H 2024 to US$0.0614 in 1H 2025 and US$0.0607 in 2H 2025. This sets the backdrop for investors weighing...

CIMC Enric Holdings (SEHK:3899) has laid out its latest scorecard with FY 2025 first half revenue of about C¥12.6b and basic EPS of C¥0.28, giving investors fresh data to weigh against the current share price of HK$11.10. Over the past few periods, the company has seen revenue move from C¥11.5b and EPS of C¥0.24 in 1H 2024 to C¥13.3b and EPS of C¥0.30 in 2H 2024. Trailing twelve month revenue most recently sat at roughly C¥26.3b with EPS of C¥0.56, putting the spotlight on how consistently it...

Guangzhou Innogen Pharmaceutical Group (SEHK:2591) has reported its FY 2025 first half with revenue of C¥56.4 million, a basic EPS loss of C¥0.29 and net income loss of C¥122.47 million, while trailing twelve month figures show revenue of C¥131.5 million, a basic EPS loss of C¥0.79 and net income loss of C¥341.36 million. The company has seen first half revenue move from C¥0 in FY 2024 to C¥56.4 million in FY 2025 as EPS moved from a basic loss of C¥0.18 to a loss of C¥0.29. This sets up a...

Giordano International (SEHK:709) has put up a steady set of FY 2025 numbers, with first half revenue at HK$1,934 million and basic EPS of HK$0.075, supported by trailing twelve month revenue of HK$3,854 million and EPS of HK$0.134 that frame the latest run rate. The company has seen revenue move from HK$1,903 million in the first half of FY 2024 to HK$2,016 million in the second half and then to HK$1,934 million in the first half of FY 2025, while basic EPS tracked HK$0.074 in early FY...

Tradelink Electronic Commerce (SEHK:536) has opened FY 2025 with first half revenue of HK$121.0 million and basic EPS of HK$0.0526, alongside trailing twelve month revenue of HK$252.7 million and EPS of HK$0.106 that frame the latest figures in a broader context. Over recent periods, revenue has moved between HK$122.7 million and HK$125.0 million per half while basic EPS has ranged from HK$0.0512 to HK$0.0526, setting a relatively tight band for top line and per share performance as you look...

China Railway Signal & Communication (SEHK:3969) has reported its FY 2025 results with fourth quarter revenue of about C¥12.9b and basic EPS of C¥0.11. This is set against a trailing twelve month EPS of C¥0.34 that reflects 5.5% earnings growth over the past year and a net profit margin of 10.6%. Over recent periods, revenue has moved from roughly C¥11.7b in Q4 2024 to C¥12.9b in Q4 2025, while quarterly EPS shifted from C¥0.10 to C¥0.11 on this comparison. With earnings growth outpacing the...

Health and Happiness (H&H) International Holdings (SEHK:1112) has reported FY 2025 first half revenue of C¥7.0b and basic EPS of C¥0.11, with the trailing twelve months showing revenue of C¥14.4b and basic EPS of C¥0.31 as profitability returned over the year. The company has seen revenue move from C¥6.7b in 1H 2024 to C¥7.0b in 1H 2025, while basic EPS shifted from C¥0.48 in 1H 2024 to C¥0.11 in 1H 2025. This sets up a results season in which investors will be weighing the earnings rebound...

Best Pacific International Holdings (SEHK:2111) has posted its FY 2025 first half results with revenue of HK$2,329.8 million and basic EPS of HK$0.25, setting the tone against a backdrop of forecast earnings growth of about 18.6% per year and revenue growth of roughly 8.8% per year. The company has seen revenue move from HK$2,385.4 million in 1H 2024 to HK$2,675.9 million in 2H 2024 and then to HK$2,329.8 million in 1H 2025, while EPS has shifted from HK$0.27 to HK$0.32 and now HK$0.25. This...

Haidilao International Holding (SEHK:6862) has wrapped up FY 2025 with second half revenue of C¥22.5b and basic EPS of C¥0.42, while trailing twelve month revenue sits at C¥43.2b and EPS at C¥0.75. This frames a set of results that investors can benchmark against both recent and multi year growth. The company has seen half year revenue move from C¥21.3b in 2H 2024 to C¥22.5b in 2H 2025, with basic EPS shifting from C¥0.49 to C¥0.42 over the same period. This sets up a debate about how profit...

WuXi Biologics (Cayman) (SEHK:2269) has reported its FY 2025 numbers with second half revenue of about C¥11.8b and basic EPS of C¥0.64, supported by trailing twelve month revenue of roughly C¥21.8b and EPS of C¥1.22 that sit alongside a 46.3% year over year earnings gain. The company has seen revenue move from around C¥18.7b to C¥21.8b on a trailing basis, while trailing EPS has shifted from C¥0.82 to C¥1.22, setting up a story where rising profit levels are paired with healthier margins that...

Duality Biotherapeutics (SEHK:9606) has just posted its FY 2025 first half results, with revenue of C¥1.2b and a basic EPS loss of C¥49.73, set against a net income loss of C¥2.1b. Over the same half year a year earlier, the company reported revenue of C¥1.0b and a basic EPS loss of C¥36.68, while trailing twelve month figures show revenue of C¥1.9b and a basic EPS loss of C¥39.80 as losses widened to C¥2.6b. For investors, the key theme this period is the tension between increasing revenue...

MIXUE Group (SEHK:2097) FY 2025 earnings snapshot MIXUE Group (SEHK:2097) has reported FY 2025 results with second half revenue of C¥18.7b and basic EPS of C¥2.82, alongside trailing 12 month revenue of C¥33.6b and EPS of C¥7.83, giving investors a fresh look at how the business is scaling. The company has seen revenue move from C¥10.7b and EPS of C¥5.23 in the first half of 2024 to C¥14.9b and EPS of C¥7.23 in the first half of 2025, with trailing 12 month revenue stepping up from C¥24.8b...

Ping An Healthcare and Technology (SEHK:1833) has just posted its FY 2025 first half numbers, with revenue at C¥2.5b and basic EPS of C¥0.07, alongside net income of C¥134.2m that builds on its recent move into profitability. Over the recent reporting periods, revenue has shifted from C¥2.1b in 1H 2024 to C¥2.7b in 2H 2024 and C¥2.5b in 1H 2025, while basic EPS has moved from C¥0.05 in 1H 2024 to C¥0.02 in 2H 2024 and C¥0.07 in 1H 2025. This sets up a results story where investors will be...

Orient Overseas (International) (SEHK:316) shares were in focus after the company reported full year 2025 results showing lower sales and net income, alongside a proposed final dividend of US$0.42 per share payable in multiple currencies. See our latest analysis for Orient Overseas (International). The latest earnings update, which includes lower sales and net income alongside a proposed US$0.42 dividend, comes as the share price sits at HK$144.2 with a 90 day share price return of 16.1%. The...

What the latest results and board changes mean for Samsonite Group Samsonite Group (SEHK:1910) just packed several developments into one update, combining full year 2025 earnings, a proposed US$140 million dividend, a planned chairmanship handover and shareholder approval to prepare for a potential US dual listing. See our latest analysis for Samsonite Group. Those announcements landed after a tough stretch for the stock, with a 30 day share price return of 23.03% decline and a year to date...

Link Real Estate Investment Trust (SEHK:823) held its nine months 2026 operating results call on 16 March, giving investors fresh detail on portfolio performance, income drivers and recent share price moves. See our latest analysis for Link Real Estate Investment Trust. The units have shown mixed momentum, with a 3.6% 90 day share price return and 3.1% 1 year total shareholder return. The recent nine month update and HK$36.28 price are being weighed against weaker 3 and 5 year total...

Earnings guidance points to sharp swing into loss Zhongsheng Group Holdings (SEHK:881) issued new earnings guidance indicating a loss of no more than CN¥2.0b for 2025, compared with a CN¥3.2b profit in 2024, highlighting a material shift in profitability. The company links this swing to ongoing gross losses in its automobile business amid weak domestic consumer demand, supply and demand imbalances in passenger vehicles, tougher competition, reduced automobile financing commissions, and up to...

Profit warning shifts focus to earnings guidance details Shandong Hi-Speed Holdings Group (SEHK:412) has issued earnings guidance for 2025, telling investors it expects unaudited net profit of at least CN¥140 million, compared with audited net profit of about CN¥693 million in 2024. The Board attributes the projected profit drop mainly to realised losses on disposal of debt instruments, lower interest income from financial assets, and higher income tax expenses, partly offset by higher fair...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has reported FY 2025 first half revenue of C¥950.4 million with a basic EPS loss of C¥0.64, while trailing twelve month revenue stands at C¥2.1 billion and basic EPS over that period is a loss of C¥3.20. The company has seen revenue move from C¥1.38 billion in 1H 2024 to C¥550.3 million in 2H 2024 and C¥950.4 million in 1H 2025, with EPS shifting from a profit of C¥1.41 in 1H 2024 to losses of C¥2.59 in 2H 2024 and C¥0.64 in 1H 2025...

This article examines whether KLN Logistics Group at HK$6.65 could be a potential bargain or a value trap, and walks through key signals to help you frame that question clearly. The stock has recently been under pressure, with returns of 1.8% over 7 days, 4.9% over 30 days, 7.9% year to date and 0.8% over the past year, alongside declines of 39.0% and 50.4% across 3 and 5 years respectively. Recent attention around KLN Logistics Group has focused less on short term headlines and more on how...

Celebrations may be in order for CK Hutchison Holdings Limited ( HKG:1 ) shareholders, with the analysts delivering a...

New Amante Group Limited ( HKG:8412 ) insiders who bought shares over the past year were rewarded handsomely last week...